C326

· Avidia

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for C326, covering 2006-10-11 to 2006-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease [Phase 1]